Tabula Rasa HealthCare Saham

Tabula Rasa HealthCare EBITDA

Delisted

EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) dari Tabula Rasa HealthCare (TRHC) pada 25 Agu 2026 adalah -44,56 Juta. USD. Tahun sebelumnya, EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) adalah -48,84 Juta. USD — perubahan sebesar -8,75% (lebih tinggi).

EBITDA

-44,56 Juta.USD

YoY

-8,75%

Terakhir Diperbarui:

EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) dari Tabula Rasa HealthCare adalah 2026 -44,56 Juta. USD. EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) dari Tabula Rasa HealthCare adalah 2025 -48,84 Juta. USD. Menurun -8,75% lebih tinggi dibandingkan dengan tahun sebelumnya.

Sejarah Tabula Rasa HealthCare EBITDA

  • 3 tahun

  • 10 tahun

  • 25 Tahun

  • Maks

EBITDA
Date
EBITDA
1 Jan 2015
10,07 Juta. USD
1 Jan 2016
9,65 Juta. USD
1 Jan 2017
14,70 Juta. USD
1 Jan 2018
16,53 Juta. USD
1 Jan 2019
5,47 Juta. USD
1 Jan 2020
-12,74 Juta. USD
1 Jan 2021
-48,84 Juta. USD
1 Jan 2022
-44,56 Juta. USD
Sejarah Tabula Rasa HealthCare EBITDA
TAHUNEBITDAYoY
-44,56 Juta.USD-8,75%
-48,84 Juta.USD+283,41%
-12,74 Juta.USD-333,00%
5,47 Juta.USD-66,92%
16,53 Juta.USD+12,43%
14,70 Juta.USD+52,33%
9,65 Juta.USD-4,11%
10,07 Juta.USD+427,79%
1,91 Juta.USD
Access this data via the Eulerpool API

Tabula Rasa HealthCare Analisis saham

Apa yang dilakukan Tabula Rasa HealthCare? Tabula Rasa HealthCare Inc is a US-based company specializing in the development of innovative healthcare solutions. The company was founded in 2009 by CEO and Chairman Calvin H. Knowlton and is headquartered in Moorestown, New Jersey. The business model of Tabula Rasa Healthcare offers a wide range of technology solutions focused on improving clinical processes and patient safety. These technology solutions are incorporated into its medication management programs and include electronic medication profiles and clinical decision support systems. By adding SinfoniaRx, Tabula Rasa HealthCare is able to provide a holistic approach to improving medication adherence and compliance. The company offers a broad range of services to enable efficient monitoring of medication effects. Tabula Rasa HealthCare's technology enables personalized medication delivery to ensure that each patient receives the right medication at the right time. Tabula Rasa HealthCare operates in three business divisions: medication safety, medication therapy management, and population health management. In the field of medication safety, the company provides solutions that enable medical personnel to conduct a comprehensive assessment of a patient's medical history and create an accurate medication list. The company also offers support for risk assessment and medication management in patients with multiple or complex chronic conditions. The medication therapy management division covers a range of individual measures aimed at monitoring medication therapies. Tabula Rasa HealthCare's solutions assist healthcare professionals in better understanding patients' medication and improving treatment outcomes. In the population health management field, the company offers tools and strategies for optimizing communicative data analysis to minimize patient requirements and healthcare costs. The company provides technology solutions to revolutionize patient care through the integration of data analytics and a focus on preventive measures. This helps patients achieve better treatment outcomes, detect diseases at an early stage, and save costs. In summary, Tabula Rasa HealthCare Inc is a company focused on developing technology solutions to improve medical decision-making and maximize patient safety. The company utilizes its expertise in various areas and provides customized solutions to ensure personalized and optimized medication delivery. Its business model includes a holistic approach to improving medication adherence and compliance. Tabula Rasa HealthCare is driving medical research and the development of technology solutions to revolutionize modern patient care. Tabula Rasa HealthCare adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Tabula Rasa HealthCare

EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) Tabula Rasa HealthCare adalah -44,56 Juta. USD pada tahun 2026.

EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) dari Tabula Rasa HealthCare berubah dari -48,84 Juta. USD menjadi -44,56 Juta. USD, mewakili perubahan -8,75%. Nilainya lebih tinggi daripada tahun sebelumnya.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) Tabula Rasa HealthCare sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

EBITDA mengukur kinerja operasional sebelum dampak struktur keuangan, lingkungan pajak, dan biaya penyusutan non-kas.

EBITDA = EBIT + Penyusutan & Amortisasi

USD EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) adalah faktor kunci bagi investor. Perubahan metrik ini dapat menunjukkan fundamental yang membaik atau memburuk, secara langsung memengaruhi harga saham. Di Eulerpool, Anda dapat melacak Tabula Rasa HealthCare EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) secara historis dan real-time.

Access this data via the Eulerpool API

Laporan Laba Rugi — Tabula Rasa HealthCare

Semua Metrik Kunci — Tabula Rasa HealthCare